Literature DB >> 99232

Concurrent depression of tumor macrophage infiltration and systemic inflammation by progressive cancer growth.

S J Normann, J Cornelius.   

Abstract

Macrophage accumulation during the growth of a peritoneal ascites and three s.c. tumors in two animal species was analyzed and correlated with the capacity of the same tumor-bearing host to respond to inflammatory stimuli at sites distant to the tumor. Two of the three s.c. tumors induced systemic defects in macrophage accumulation; the tumor that did not (P-815 mastocytoma) did depress inflammation when transplanted to the peritoneal site. Macrophage accumulation within different tumors varied but, for a given tumor, it occurred in proportion to tumor growth when systemic inflammatory reactions were normal. However, the tumor to macrophage ratio increased dramatically and concurrently with onset of the generalized defect in macrophage inflammatory responsiveness. Accordingly, we concluded that macrophage mobility tested at remote sites is indicative of inflammatory events within the tumor. However, the antiinflammatory effect directed against macrophages is probably not a significant factor in tumor emergence since the required number of tumor cells was large and variable between not only tumors but also sites of transplantation.

Entities:  

Mesh:

Year:  1978        PMID: 99232

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Participation of Tumor-Associated Myeloid Cells in Progression of Amelanotic Melanoma (RMM Tumor Line) in F344 Rats, with Particular Reference to MHC Class II- and CD163-Expressing Cells.

Authors:  A Bondoc; H M Golbar; M Pervin; C Katou-Ichikawa; M Tanaka; T Izawa; M Kuwamura; J Yamate
Journal:  Cancer Microenviron       Date:  2017-06-16

Review 2.  Macrophage infiltration and tumor progression.

Authors:  S J Normann
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 3.  Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?

Authors:  Fangyi Zhao; Ziqian Cheng; Jingjing Piao; Ranji Cui; Bingjin Li
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

4.  Changes in the macrophage content of lung metastases at different stages in tumor growth.

Authors:  P J Bugelski; R L Kirsh; J M Sowinski; G Poste
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

5.  Serum biochemical changes in c. parvum-injected mice bearing the Landschütz ascites carcinoma.

Authors:  L C McIntosh; A W Thomson; P H Whiting
Journal:  Br J Exp Pathol       Date:  1982-12

Review 6.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

7.  Inhibition of monocyte complement receptor enhancement by low molecular weight material from human lung cancers.

Authors:  E J Glass; C A Abell; A B Kay
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

8.  Recruitment of exogenous macrophages into metastases at different stages of tumor growth.

Authors:  P J Bugelski; R Kirsh; C Buscarino; S P Corwin; G Poste
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells.

Authors:  A Szuro-Sudol; C F Nathan
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Inhibition by the Landschütz ascites carcinoma of the granulomatous inflammatory response to C. parvum.

Authors:  L C McIntosh; R G Pugh-Humphreys; R A Fraser; A W Thomson
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.